Muscle Metabolism and Oxygenation During Localized Fatigue-exercise in COPD

February 6, 2014 updated by: Fernanda Ribeiro, Laval University

Muscle Oxygenation and Metabolism in Response to a Localized Fatigue-inducing Exercise in Patients With Chronic Obstructive Pulmonary Disease

The purpose of this study is to investigate whether a localized exercise, in which cardiorespiratory demand is reduced, will result in greater limb muscle fatigue in patients with COPD as a consequence of muscle oxygenation and muscle metabolism disturbances.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Quebec
      • Québec, Quebec, Canada, G1V 4G5
        • Recruiting
        • Institut Universitaire de Cardiologie et de Pneumologie de Quebec
        • Principal Investigator:
          • François Maltais, MD
        • Sub-Investigator:
          • Didier Saey, PhD
        • Sub-Investigator:
          • Fernanda Ribeiro, PhD candidate

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • COPD (FEV1/FVC < 0.70 and FEV1 < 0.80 predicted
  • Healthy subjects: no evidence of airways obstruction (FEV1/FVC > 0.70 and FEV1 > 0.80 predicted)
  • Smoking history > 15 pack-years

Exclusion Criteria:

  • Chronic hypoxemia and/or hypercapnia (PaO2 < 60 mmHg or SpO2 < 88% at rest and/or PaCO2 > 45 mmHg)
  • Recent exacerbation (< 3 months)
  • Recent cancer (< 3 years)
  • Diabetes
  • Myopathy, neuromuscular or articular disease
  • Unstable cardiac disease
  • Absolute contraindications to exercise testing
  • Regular physical activity or exercise training program in the last 2 months
  • Physical activity score > 9 in the Voorips questionnaire
  • Thigh skinfold thickness > 15 mm
  • BMI > 30

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Oxygen
All participants (patients and healthy subjects) will perform the exercise both under normoxic (FiO2 = 0.21) and hyperoxic conditions (FiO2 = 100%)
Sham Comparator: Room air
All participants (patients and healthy subjects) will perform the exercise both under normoxic (FiO2 = 0.21) and hyperoxic conditions (FiO2 = 100%)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle deoxygenation
Time Frame: 45 seconds post-exercise (knee-extension repetitions)
Changes of deoxyhemoglobin/myoglobin concentrations measured by near-infrared spectroscopy of vastus lateralis muscle.
45 seconds post-exercise (knee-extension repetitions)
Muscle metabolism
Time Frame: 45 seconds post-exercise (knee extension repetitions)
Changes in glycolytic and oxidative metabolism pathway markers, energy substrates (glycogen and glucose), end-products of glycolysis (pyruvate, and lactate), intermediate markers of glycolysis and high-energy phosphate compounds obtained from muscle biopsies
45 seconds post-exercise (knee extension repetitions)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ventilatory response
Time Frame: Baseline, beginning and end of each serie of knee extensions (fatiguing exercise)
Minute ventilation will be monitored during the fatigue-inducing exercise and it will be compared between subjects and conditions (FiO2 = 21% vs. FiO2 = 100%)
Baseline, beginning and end of each serie of knee extensions (fatiguing exercise)
Quadriceps muscle fatigue
Time Frame: baseline, 15 min and 40 min after the fatigue-inducing exercise

Quadriceps muscle fatigue will be determined by loss of quadriceps strength measured by magnetic stimulation after the fatigue-inducing exercise.

Surface electromyography will also be measured to characterize muscle fatigue.

baseline, 15 min and 40 min after the fatigue-inducing exercise
total muscle work
Time Frame: end of fatiguing exercise
Total muscle work performed during fatigue-inducing exercise that will be composed by subsequent isokinetic knee-extensions repetitions at 40% of maximal peak torque
end of fatiguing exercise

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: François Maltais, MD, Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2011

Primary Completion (Anticipated)

July 1, 2014

Study Registration Dates

First Submitted

July 16, 2013

First Submitted That Met QC Criteria

July 23, 2013

First Posted (Estimate)

July 26, 2013

Study Record Updates

Last Update Posted (Estimate)

February 7, 2014

Last Update Submitted That Met QC Criteria

February 6, 2014

Last Verified

February 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Disease, Chronic Obstructive

Clinical Trials on Fatiguing exercise

3
Subscribe